FusionPharm receives 11 unit order

Denver, Colorado, Aug. 20, 2013 (GLOBE NEWSWIRE) -- August 20, 2013 /PRNewswire via COMTEX/ -- Meadpoint Venture Partners, Inc., the exclusive licensee of FusionPharm's patent pending PharmPodsTM High Intensity container hydroponic cultivation system (www.pharmpods.com), today announced that GroundSwell cannabis boutique (www.groundswelldenver.com) located in Denver Colorado is now making the transition to exclusively utilizing the PharmPod system with an additional 11 unit purchase.

Don Novak of Groundswell is quoted as stating "Nowhere else but with Pharm Pods can you get an 88 light facility up and running in less than two weeks. It's truly amazing!"

About FusionPharm Inc. (FSPM)

FusionPharm, Inc. (FSPM) (www.fusionpharminc.com) was organized to capitalize on opportunities present in the rapidly growing vertical farming and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods™ advanced hydroponic commercial cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Modular, stackable, cost competitive and financeable, PharmPods have become the industry leader for professional, commercial scale indoor plant cultivation.

About Meadpoint Venture Partners.

Meadpoint Venture Partners is the exclusive licensee of the FusionPharm High Intensity flowering container cultivation system. Meadpoint is currently conducting a multistate sales campaign to show industry professionals the potential of HI containers as an effective and economical medium for the cultivation of fruiting and flowing plants in a high-growth industry."

About Groundswell

GroundSwell Cannabis Boutique is a professional, high-quality, full-service medical marijuana center with a patient-centric approach to dispensing the highest quality medicine for your condition. We pride ourselves on providing a unique, friendly and welcoming environment for all patients, with a knowledgeable staff that cares about your needs.

NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

Source:FusionPharm, Inc.